The company has an elaborate products portfolio in terms of number of pyridine/pyridine-based products offered, hence, serving a wider range of end users. The company is focusing on R&D, which is evident in the launch of new products which were permitted to be manufactured by the Chinese government. Considering all the factors, the overall product offering of the company is good. Source: Secondary Research and MarketsandMarkets Analysis